Zinc-Based Nanoparticles, but Not Silicon-Based Nanoparticles, Accumulate in Mitochondria and Promote Cell Death in Liver Cancer Cells.

IF 6.6 2区 医学 Q1 NANOSCIENCE & NANOTECHNOLOGY
International Journal of Nanomedicine Pub Date : 2024-11-23 eCollection Date: 2024-01-01 DOI:10.2147/IJN.S474643
Joana C Pieretti, Thaissa L Horne, Natalia García-Villasante, Amedea B Seabra, Jordi Muntané
{"title":"Zinc-Based Nanoparticles, but Not Silicon-Based Nanoparticles, Accumulate in Mitochondria and Promote Cell Death in Liver Cancer Cells.","authors":"Joana C Pieretti, Thaissa L Horne, Natalia García-Villasante, Amedea B Seabra, Jordi Muntané","doi":"10.2147/IJN.S474643","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Hepatocellular carcinoma (HCC) is the main hepatic primary malignancy. Patients with advanced HCC receiving the recommended therapies have a poor outcome. In different settings, nanotechnology has gained attraction as a potential alternative strategy for improving therapeutic effectiveness. Among several nanoparticles (NPs), inorganic NPs, such as zinc and silicon oxides (ZnO and SiO<sub>2</sub>), are mainly chosen as drug nanocarriers, as both present great adsorption properties and biocompatibility.</p><p><strong>Aim: </strong>The objective is to identify the molecular mechanisms underlying the proapoptotic effects of ZnO and SiO<sub>2</sub> NPs in differentiated hepatoblastoma cells (HepG2) and mesenchymal liver cancer cells (SNU449).</p><p><strong>Methods: </strong>Dose-dependent induction of cell cytotoxicity by ZnO and SiO<sub>2</sub> NPs (5 to 50 µg/mL) was determined in HepG2 and SNU449 cells. NPs intracellular localization was assessed using transmission electron microscopy (TEM). Cell death was determined by trypan blue staining and caspase-3 and -8 activities. Cell respiration was determined using MitroStress assay (Seahorse, Agilent).</p><p><strong>Results: </strong>ZnO NPs, but not SiO<sub>2</sub> NPs, reduced cell viability in HepG2 and SNU449. Interestingly, SNU449 appeared to be more susceptible than HepG2 to ZnO NPs (IC50 of 27.4 ± 1.4 µg/mL and 41.8 ± 0.4 µg/mL, respectively). SiO<sub>2</sub> NPs tended to be localized in lysosomes in both cell lines, while ZnO NPs demonstrated a random distribution with a high presence in mitochondria and related structures. As expected, SiO<sub>2</sub> NPs did not reduce cell survival and cell respiration, while ZnO NPs promoted cell death and decreased oxygen consumption rate. ZnO NPs mitochondrial accumulation was associated with increased apoptosis in HepG2, while necroapoptosis was mainly involved in ZnO-induced cell death in SNU449.</p><p><strong>Conclusion: </strong>SiO<sub>2</sub> demonstrated no cytotoxic profile against liver cancer cells. ZnO NPs demonstrated to accumulate in mitochondria impacting cell respiration and cell death in liver cancer cells. ZnO induced apoptosis and necroptosis in HepG2 and SNU449, respectively.</p>","PeriodicalId":14084,"journal":{"name":"International Journal of Nanomedicine","volume":"19 ","pages":"12409-12420"},"PeriodicalIF":6.6000,"publicationDate":"2024-11-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11600939/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Nanomedicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/IJN.S474643","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"NANOSCIENCE & NANOTECHNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Hepatocellular carcinoma (HCC) is the main hepatic primary malignancy. Patients with advanced HCC receiving the recommended therapies have a poor outcome. In different settings, nanotechnology has gained attraction as a potential alternative strategy for improving therapeutic effectiveness. Among several nanoparticles (NPs), inorganic NPs, such as zinc and silicon oxides (ZnO and SiO2), are mainly chosen as drug nanocarriers, as both present great adsorption properties and biocompatibility.

Aim: The objective is to identify the molecular mechanisms underlying the proapoptotic effects of ZnO and SiO2 NPs in differentiated hepatoblastoma cells (HepG2) and mesenchymal liver cancer cells (SNU449).

Methods: Dose-dependent induction of cell cytotoxicity by ZnO and SiO2 NPs (5 to 50 µg/mL) was determined in HepG2 and SNU449 cells. NPs intracellular localization was assessed using transmission electron microscopy (TEM). Cell death was determined by trypan blue staining and caspase-3 and -8 activities. Cell respiration was determined using MitroStress assay (Seahorse, Agilent).

Results: ZnO NPs, but not SiO2 NPs, reduced cell viability in HepG2 and SNU449. Interestingly, SNU449 appeared to be more susceptible than HepG2 to ZnO NPs (IC50 of 27.4 ± 1.4 µg/mL and 41.8 ± 0.4 µg/mL, respectively). SiO2 NPs tended to be localized in lysosomes in both cell lines, while ZnO NPs demonstrated a random distribution with a high presence in mitochondria and related structures. As expected, SiO2 NPs did not reduce cell survival and cell respiration, while ZnO NPs promoted cell death and decreased oxygen consumption rate. ZnO NPs mitochondrial accumulation was associated with increased apoptosis in HepG2, while necroapoptosis was mainly involved in ZnO-induced cell death in SNU449.

Conclusion: SiO2 demonstrated no cytotoxic profile against liver cancer cells. ZnO NPs demonstrated to accumulate in mitochondria impacting cell respiration and cell death in liver cancer cells. ZnO induced apoptosis and necroptosis in HepG2 and SNU449, respectively.

锌基纳米粒子(而非硅基纳米粒子)在线粒体中聚集并促进肝癌细胞死亡
简介肝细胞癌(HCC)是主要的肝原发性恶性肿瘤。晚期肝细胞癌患者接受推荐疗法的疗效不佳。在不同的情况下,纳米技术作为一种潜在的替代策略,在提高治疗效果方面获得了吸引力。在几种纳米粒子(NPs)中,无机纳米粒子,如锌和硅氧化物(ZnO和SiO2),主要被选为药物纳米载体,因为它们都具有很好的吸附特性和生物相容性:方法:测定了 ZnO 和 SiO2 NPs(5 至 50 µg/mL)在 HepG2 和 SNU449 细胞中诱导细胞细胞毒性的剂量依赖性。使用透射电子显微镜(TEM)评估了NPs在细胞内的定位。细胞死亡是通过胰蓝染色和 Caspase-3 及 -8 活性来确定的。使用 MitroStress 分析法(Seahorse,安捷伦)测定细胞呼吸:结果:ZnO NPs(而非 SiO2 NPs)降低了 HepG2 和 SNU449 的细胞活力。有趣的是,SNU449 似乎比 HepG2 更易受 ZnO NPs 的影响(IC50 分别为 27.4 ± 1.4 µg/mL 和 41.8 ± 0.4 µg/mL)。在这两种细胞系中,SiO2 NPs 都倾向于定位于溶酶体,而 ZnO NPs 则表现出随机分布,线粒体和相关结构中存在较多。正如所料,SiO2 NPs 不会降低细胞存活率和细胞呼吸率,而 ZnO NPs 则会促进细胞死亡并降低耗氧率。在 HepG2 中,ZnO NPs 线粒体积累与细胞凋亡增加有关,而在 SNU449 中,ZnO 诱导的细胞死亡主要涉及细胞坏死:结论:二氧化硅对肝癌细胞没有细胞毒性。结论:二氧化硅对肝癌细胞无细胞毒性,而氧化锌纳米粒子在线粒体中聚集,影响肝癌细胞的呼吸和细胞死亡。氧化锌可分别诱导 HepG2 和 SNU449 细胞凋亡和坏死。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
International Journal of Nanomedicine
International Journal of Nanomedicine NANOSCIENCE & NANOTECHNOLOGY-PHARMACOLOGY & PHARMACY
CiteScore
14.40
自引率
3.80%
发文量
511
审稿时长
1.4 months
期刊介绍: The International Journal of Nanomedicine is a globally recognized journal that focuses on the applications of nanotechnology in the biomedical field. It is a peer-reviewed and open-access publication that covers diverse aspects of this rapidly evolving research area. With its strong emphasis on the clinical potential of nanoparticles in disease diagnostics, prevention, and treatment, the journal aims to showcase cutting-edge research and development in the field. Starting from now, the International Journal of Nanomedicine will not accept meta-analyses for publication.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信